News|Articles|January 20, 2025

Study Affirms Effectiveness of Vaccination "Ring" Around Ebola

Promptly vaccinating the "ring" of contacts and contacts-of-contacts along with standard infection control measures interrupted Ebola transmission in the DRC.

Promptly vaccinating the "ring" of contacts and contacts-of-contacts of persons contracting Ebola, in conjunction with standard infection control measures, was found to reduce emergence of cases within 10 days of vaccination, in a study1 of time-response to the strategy in the 2018-2020 outbreak in the Democratic Republic of Congo (DRC).

The study with the single-dose, live-replicating rVSVΔG-ZEBOV-GP vaccine (Ervebo) reinforces earlier findings2 from the 2014-2016 outbreak in Guineathat the ring vaccination strategy, used successfully in eradicating small pox a half century earlier, in conjunction with standard infection control measures is more effective immediately after an active case is identified than when delayed until after control measures are in place or a population-wide program can be implemented.

In the DRC study, investigators distinguished the emergence of Ebola virus disease (EVD) between rings of vaccination accomplished within 0 to 9 days (380 cases) or 10 to 20 days (32 cases) after identifying and isolating an infected person. 1,853 rings of vaccination were established around new cases or clusters within 21 days after symptom onset in the index case.A total of 265,183 participants were vaccinated during the outbreak, of which 102,515 were monitored on days 0, 3, and 21 for safety.

The investigators reported that the sooner the infection control measures, including vaccination, was implemented after the index case was identified and isolated, the sooner EVD rates decreased among vaccinated contacts.In each subgroup, EVD rates fell suddenly around day 10 after vaccination.

Among contacts and contacts-of-contacts who were uninfected at day 10, the EVD onset rate during days 10 to 29 was 0.16/1000.The investigators contrast this to the rate of 4.64/1000 that had occurred in Guinea in the group that was subject to immediate control measures but a delay in vaccination until day 21 after identifying the ring of contacts.

Jean-Jacques Muyembe, PhD, on Combating Ebola

The lead author of the DRC study is Jean-Jacques Muyembe, PhD, director of the Institut National de Recherche Biomédicale (INRB) and codiscoverer of the Ebola virus. Muyembe discussed the study with Contagion, remarking on the many challenges that were encountered in the DRC campaign against EVD, including the vaccine hesitancy that confounds public health efforts across the globe.

"Vaccine hesitancy was a challenge due to misinformation, fear of outside agendas, and cultural barriers," Muyembe said. "To address this, we worked with local healthcare workers, community leaders, and trusted influencers to explain the vaccine's safety and importance. Their involvement helped ensure the message resonated with communities."

Control measures were implemented by teams charged with four key tasks, Muyembe explained:

  • Defining the ring—listing contacts and contacts-of-contacts from the case data provided by the DRC Ministry of Health and the WHO surveillance teams
  • Obtaining informed consent—ensuring vaccine recipients understood and agreed to vaccination
  • Vaccine administration—delivering the vaccine
  • Safety follow-up—Monitoring vaccines post-vaccination

"All team members were trained in good clinical practices, the study protocol, and the standard operating procedures for ring vaccination," Muyembe said."Surveillance teams focused on identifying cases and tracing contacts, often with support from community members. Laboratory teams tested suspected cases to confirm or rule out Ebola.

"In areas with security concerns, military or UN peacekeepers provided protection for vaccination teams, but did not engage with the communities directly, preserving trust in the health workers," Muyembe noted.

With the study confirming the importance of prompt ring vaccination, Muyembe described the efforts to hasten recognition and reporting of an Ebola infection."Early detection is critical for the success of the ring vaccination strategy and the outbreak response as a whole," he declared.

"We accelerated case recognition through public health campaigns that educated communities on Ebola symptoms and encouraged timely reporting. Community health workers played a vital role by linking suspected cases to response teams using hotlines and other communication tools. These efforts reduced delays in identifying and isolating cases," Muyembe recounted.

References
1. Muyembe JJ, Pan H, Petro R, et al. Ebola outbreak response in the DRC with rVSV-ZEBOV-GP ring vaccination. N Engl J Med 2024; 391(24):2327-2336.
2. Ebola ça Suffit Ring Vaccination Trial Consortium. The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola. BMJ. 2015 Jul 27;351:h3740. doi: 10.1136/bmj.h3740.

Related to this article

This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.